Key Takeaways
- Evidence-based addiction treatment is defined by rigorous clinical research including randomized controlled trials, not celebrity endorsements, social media popularity, or anecdotal testimonials.
- Some trendy therapies like ketamine-assisted therapy and mindfulness-based relapse prevention have growing scientific support, while others like NAD+ infusions and IV vitamin drips lack sufficient evidence for addiction-specific claims.
- Psychedelic-assisted therapies (psilocybin, MDMA, ibogaine) show early promise in clinical trials but remain experimental, carry risks, and should only be considered within supervised research settings.
- The greatest danger of trendy treatments is not the treatments themselves but the risk that they replace rather than complement proven evidence-based interventions like CBT, MAT, and structured aftercare.
- Trust SoCal integrates complementary approaches that have scientific support while maintaining a clinical foundation built on the treatments with the strongest evidence base.
The Celebrity Wellness Pipeline to Addiction Treatment
The line between celebrity wellness culture and addiction treatment has become increasingly blurred. Social media influencers and public figures regularly promote wellness interventions, from IV vitamin infusions and hyperbaric oxygen chambers to sound baths and plant medicine ceremonies, as transformative experiences for mental health and recovery. Some of these endorsements are genuine reflections of personal experience, while others are paid partnerships with wellness brands seeking to capitalize on the growing market for alternative health solutions. Regardless of intent, the result is that individuals seeking help for substance use disorders are now navigating a marketplace where marketing spend and celebrity cachet often carry more weight than clinical evidence.
This trend is particularly concerning in the context of addiction treatment because the stakes are exceptionally high. Substance use disorders are potentially fatal conditions, and delays in receiving effective treatment can have irreversible consequences. When an individual chooses an unproven wellness intervention over evidence-based care, or when a treatment facility substitutes trendy offerings for clinical programming to attract a premium clientele, the consequences can range from wasted time and money to medical emergencies and death. The critical question is not whether a particular therapy is fashionable or endorsed by celebrities but whether it has been demonstrated to improve outcomes for people with substance use disorders through rigorous scientific investigation.
At Trust SoCal in Orange County, we believe that patients deserve honest, transparent information about what works and what does not. We are not opposed to complementary therapies; in fact, we incorporate approaches like mindfulness meditation, exercise therapy, and nutritional support that have evidence supporting their role as adjuncts to core clinical treatment. But we draw a clear distinction between complementary approaches that enhance evidence-based care and trendy interventions that promise shortcuts without scientific backing. The following analysis examines several popular treatments through the lens of current scientific evidence.
Treatments with Growing Scientific Support
Not every trendy therapy is baseless. Several approaches that have gained popularity through celebrity endorsement or media attention also have legitimate scientific research behind them, though the strength and maturity of that evidence varies significantly.
Ketamine-Assisted Therapy
Ketamine, an anesthetic medication that has been used safely in medical settings for decades, has emerged as a promising treatment for treatment-resistant depression and is being investigated for potential applications in addiction treatment. The FDA approved esketamine (Spravato) nasal spray for treatment-resistant depression in 2019, validating the therapeutic potential of ketamine-class compounds. Research published in the American Journal of Psychiatry has shown that ketamine can produce rapid antidepressant effects within hours, potentially bridging the gap while traditional antidepressants take weeks to reach full efficacy.
In addiction-specific research, early studies suggest that ketamine-assisted therapy may help reduce alcohol and cocaine cravings, though the evidence base remains limited compared to established treatments. A 2022 randomized controlled trial published in the American Journal of Psychiatry found that ketamine combined with mindfulness-based relapse prevention significantly reduced alcohol relapse compared to placebo. These findings are promising but preliminary, and ketamine therapy should only be administered by qualified medical professionals in clinical settings, not through unregulated infusion clinics that have proliferated in response to consumer demand.
Ketamine itself has abuse potential and can cause dissociative effects, bladder damage with chronic use, and psychological dependence. Ketamine-assisted therapy should only be pursued through licensed medical providers with addiction treatment expertise, never through unregulated clinics or self-administration.
Mindfulness-Based Relapse Prevention (MBRP)
Mindfulness-based relapse prevention is an evidence-based intervention that integrates mindfulness meditation practices with traditional cognitive-behavioral relapse prevention strategies. Developed by researchers at the University of Washington, MBRP teaches individuals to observe cravings and emotional triggers with non-judgmental awareness rather than reacting automatically. A meta-analysis published in JAMA Internal Medicine in 2014 found moderate evidence that mindfulness meditation programs improve anxiety, depression, and pain, while a 2014 study in JAMA Psychiatry found that MBRP was as effective as standard relapse prevention in reducing substance use at 12-month follow-up.
Unlike many trendy wellness interventions, mindfulness-based approaches have a robust and growing evidence base. They are most effective when integrated into a comprehensive treatment program alongside individual therapy, group therapy, and medication management when appropriate. Trust SoCal incorporates mindfulness-informed practices into our treatment programming because the evidence supports their value as complements to core clinical interventions.
Exercise and Physical Activity
Regular physical activity has substantial evidence supporting its role as an adjunct to addiction treatment. A systematic review published in the Scandinavian Journal of Medicine and Science in Sports found that exercise interventions improved treatment outcomes for substance use disorders, with particular benefits for reducing cravings, improving mood, enhancing sleep quality, and reducing anxiety and depression. Exercise stimulates the release of endorphins and endocannabinoids, supports neuroplasticity, and may help restore disrupted dopamine signaling in the brain's reward circuitry. While exercise alone is not a substitute for evidence-based addiction treatment, it is one of the most well-supported complementary interventions available.
Treatments with Insufficient or No Evidence
Several popular treatments that have been embraced by celebrity wellness culture and marketed for addiction recovery lack sufficient scientific evidence to support their claims. This does not necessarily mean they are harmful, but it does mean that individuals should not rely on them as primary or sole interventions for substance use disorders.
NAD+ (Nicotinamide Adenine Dinucleotide) Infusions
NAD+ infusions have become one of the most aggressively marketed "detox" and "recovery" treatments in the luxury wellness space, with claims that they can rapidly restore brain chemistry, eliminate withdrawal symptoms, and reverse the effects of addiction. NAD+ is a real coenzyme that plays essential roles in cellular metabolism and energy production, and NAD+ levels do decline with age and chronic substance use. However, the clinical claims made by NAD+ infusion providers far outstrip the available evidence.
As of 2026, there are no large-scale randomized controlled trials demonstrating that intravenous NAD+ infusions improve addiction outcomes, reduce withdrawal severity, or restore brain function beyond what occurs naturally with abstinence and proper nutrition. The studies that do exist are small, uncontrolled, and often funded by companies selling NAD+ products. At $1,000 to $1,500 per infusion, with protocols recommending 10 or more sessions, NAD+ therapy represents a significant financial investment for an unproven intervention. Patients considering NAD+ therapy should be aware that it is not FDA-approved for addiction treatment and should not replace evidence-based care.
IV Vitamin Therapy and "Detox" Drips
IV vitamin drips marketed as "detox" solutions, "brain recovery" formulas, or "anti-craving" cocktails have become ubiquitous in celebrity wellness culture and have migrated into the addiction treatment marketing space. While it is true that individuals with substance use disorders often have nutritional deficiencies, and that correcting those deficiencies through appropriate supplementation is clinically sound, the premium IV vitamin therapy industry makes claims that extend well beyond nutritional repletion.
For most individuals, oral supplementation guided by a physician is equally effective at addressing nutritional deficiencies and dramatically less expensive. IV administration is medically appropriate when oral absorption is compromised (as in severe malnutrition or gastrointestinal disease) but offers no additional benefit for individuals who can absorb nutrients normally. The "detox" framing is particularly misleading, as the body's liver and kidneys perform detoxification functions that cannot be meaningfully enhanced by IV vitamin infusions.
Cryotherapy, Float Tanks, and Infrared Saunas
Whole-body cryotherapy, sensory deprivation float tanks, and infrared saunas are wellness interventions that some luxury treatment facilities offer as part of their programming. While these modalities may provide temporary stress relief, relaxation, or novelty, there is no published research demonstrating that they improve substance use disorder outcomes specifically. Some individuals may find them enjoyable or subjectively beneficial as part of a broader wellness routine, but they should not be considered therapeutic interventions for addiction and should never replace evidence-based clinical programming.
The Emerging Psychedelic Research Landscape
Psychedelic-assisted therapy represents the most scientifically interesting and ethically complex area of the current "trendy treatment" landscape. Research on psilocybin for tobacco use disorder and alcohol use disorder, MDMA for PTSD (which frequently co-occurs with substance use disorders), and ibogaine for opioid use disorder has produced genuinely promising early results from well-designed clinical trials at institutions including Johns Hopkins University, NYU, and Imperial College London.
A 2022 study published in JAMA Psychiatry found that psilocybin-assisted therapy produced significantly greater reductions in heavy drinking among participants with alcohol use disorder compared to a control condition. Research on ibogaine, a psychoactive compound derived from the iboga plant, suggests it may have unique properties that address opioid withdrawal and cravings, though it carries significant cardiac risks that have resulted in fatalities in uncontrolled settings. MDMA-assisted therapy received breakthrough therapy designation from the FDA for PTSD, though its initial New Drug Application was not approved in 2024, with the FDA requesting additional data.
The critical distinction between legitimate psychedelic research and the celebrity wellness pipeline is the context in which these substances are administered. Clinical trials employ careful screening, medical supervision, standardized therapeutic protocols, and extensive integration sessions before and after psychedelic experiences. Underground or international "retreat" settings, which are often marketed through celebrity endorsements and social media, typically lack these safeguards. Individuals seeking psychedelic-assisted therapy for addiction should pursue legitimate clinical trials rather than unregulated alternative settings, and should never use psychedelic substances as a substitute for established evidence-based treatment. Trust SoCal monitors this research closely and is committed to incorporating new treatments only when they meet the rigorous evidence standards that our patients deserve. For current treatment options, call (949) 280-8360.
Psychedelic substances carry real medical and psychological risks including cardiac events (ibogaine), psychiatric emergencies, and the potential for retraumatization. Self-administered or unregulated psychedelic use is not the same as clinical psychedelic-assisted therapy and can be dangerous. If you are in crisis, call 988 (Suicide and Crisis Lifeline) or SAMHSA at 1-800-662-4357.
How to Evaluate Any Treatment Claim
In an era of aggressive marketing, celebrity endorsements, and social media health misinformation, the ability to critically evaluate treatment claims is essential for anyone navigating the addiction treatment landscape. The following framework can help individuals and families distinguish between evidence-based interventions and unproven alternatives, regardless of how they are marketed.
First, ask what level of evidence supports the treatment. The gold standard in clinical research is the randomized controlled trial (RCT), in which participants are randomly assigned to receive either the treatment being studied or a comparison condition. Results are evaluated using validated outcome measures and analyzed statistically. Meta-analyses and systematic reviews that synthesize findings across multiple RCTs provide the strongest evidence. Testimonials, anecdotal reports, and single case studies, no matter how compelling, represent the weakest forms of evidence. Second, consider the source. Is the evidence published in peer-reviewed journals, or does it come exclusively from the company or individual selling the treatment? Third, examine the claims being made. Treatments that promise rapid cures, eliminate withdrawal without medical management, or claim to work for everyone regardless of their situation should be viewed with extreme skepticism.
Choosing an addiction treatment program is one of the most important decisions a person or family will ever make. That decision should be guided by the best available scientific evidence, not by celebrity endorsements, social media trends, or marketing sophistication. Trust SoCal is committed to evidence-based care because we believe our patients deserve treatments that have been proven to work. We are located in Fountain Valley, California, and our clinical team is available to discuss our treatment approach in detail. Contact us at (949) 280-8360 for a free, confidential assessment.
- Look for treatments supported by randomized controlled trials published in peer-reviewed journals
- Be skeptical of treatments promoted primarily through celebrity endorsements or social media testimonials
- Ask whether the treatment is FDA-approved or recommended by NIDA, SAMHSA, or ASAM
- Distinguish between complementary therapies that enhance evidence-based care and alternative therapies that claim to replace it
- Beware of treatments that promise rapid cures, universal effectiveness, or elimination of withdrawal without medical supervision
- Verify the credentials of providers and ensure they hold relevant clinical licenses
Trust SoCal Editorial Team, Clinical Review Board
Editorial & Clinical Review
